Title: Nitrobenzene compounds inhibit expression of VCAM-1.
Journal: Bioorganic & medicinal chemistry letters 20010723
137-48-4
127-53-7
137-47-3
28860-09-5
6335-26-8
22179-31-3
1272756-03-2 | Benzoic acid, 4-bromo-2,6-dinitro-, methyl ester | AA000WSK | MFCD18651710
127544-88-1 | Sodium 4,4'-(m-tolylazanediyl)bis(butane-1-sulfonate) | AA000X2H | MFCD09264685
1279048-81-5 | (S)-Pyrrolidine-3-carboxamide hydrochloride | AA000XGV | MFCD22421737
1280786-78-8 | 3-Bromo-2-methyl-6-propoxypyridine | AA000XOS | MFCD18783193
14753-05-0 | 1-Chloro-2-methylpentane | AA000XZJ | MFCD00053236
1287665-60-4 | 4-Oxazolecarboxamide, N-[3-(aminocarbonyl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazol-4-yl]-2-(2-methyl-4-pyridinyl)-, hydrochloride (1:1) | AA000YAQ | MFCD30182294
129029-23-8 | Ocaperidone | AA000YQ1 | MFCD00866668
129295-31-4 | 6-Chloro-1h-indazole-3-carboxylic acid | AA000YZM | MFCD05663998
13156-04-2 | 1-tert-Butylazetidin-3-ol | AA000ZCX | MFCD02323245
13175-00-3 | 2H-Tetrazole-5-carboxylic acid, 2-methyl- | AA000ZME | MFCD19228302